Left Main Coronary Artery Disease and Outcomes after Percutaneous Coronary Intervention for Chronic Total Occlusions.
CTO
PCI
chronic total occlusion
coronary artery disease
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
30 Mar 2020
30 Mar 2020
Historique:
received:
20
02
2020
revised:
13
03
2020
accepted:
21
03
2020
entrez:
3
4
2020
pubmed:
3
4
2020
medline:
3
4
2020
Statut:
epublish
Résumé
Concomitant left main coronary artery (LMCA) disease in patients with chronic total occlusions (CTO) commonly results in referral for coronary artery bypass grafting, although the impact of LMCA in CTO patients remains largely unknown. Nevertheless, patient selection for percutaneous coronary intervention of CTOs (CTO-PCI) or alternative revascularization strategies should be based on precise evaluation of the coronary anatomy to anticipate those patients that most likely benefit from a procedure and not on strict adherence to perpetual clinical practice. Therefore, the aim of this study was to assess the impact of LMCA disease on long-term outcomes in patients undergoing percutaneous coronary intervention for CTO. We enrolled 3860 consecutive patients undergoing PCI for at least one CTO lesion and investigated the predictive value of concomitant LMCA disease. All-cause mortality was defined as the primary study endpoint. We observed that LMCA disease is significantly associated with mortality. In the Cox regression analysis, we observed a crude hazard ratio (HR) 1.59 (95% confidence interval (CI) 1.23-2.04, LMCA disease is associated with excess mortality in CTO patients. Specifically, anatomical features such as CTO of the circumflex artery represent a high risk patient population.
Sections du résumé
BACKGROUND
BACKGROUND
Concomitant left main coronary artery (LMCA) disease in patients with chronic total occlusions (CTO) commonly results in referral for coronary artery bypass grafting, although the impact of LMCA in CTO patients remains largely unknown. Nevertheless, patient selection for percutaneous coronary intervention of CTOs (CTO-PCI) or alternative revascularization strategies should be based on precise evaluation of the coronary anatomy to anticipate those patients that most likely benefit from a procedure and not on strict adherence to perpetual clinical practice. Therefore, the aim of this study was to assess the impact of LMCA disease on long-term outcomes in patients undergoing percutaneous coronary intervention for CTO.
METHODS
METHODS
We enrolled 3860 consecutive patients undergoing PCI for at least one CTO lesion and investigated the predictive value of concomitant LMCA disease. All-cause mortality was defined as the primary study endpoint.
RESULTS
RESULTS
We observed that LMCA disease is significantly associated with mortality. In the Cox regression analysis, we observed a crude hazard ratio (HR) 1.59 (95% confidence interval (CI) 1.23-2.04,
CONCLUSION
CONCLUSIONS
LMCA disease is associated with excess mortality in CTO patients. Specifically, anatomical features such as CTO of the circumflex artery represent a high risk patient population.
Identifiants
pubmed: 32235416
pii: jcm9040938
doi: 10.3390/jcm9040938
pmc: PMC7231249
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Res Cardiol. 2018 Mar;107(3):259-267
pubmed: 29134346
JACC Cardiovasc Interv. 2008 Jun;1(3):295-302
pubmed: 19463316
Rev Esp Cardiol. 2009 Jul;62(7):719-25
pubmed: 19709505
Can J Cardiol. 2014 Dec;30(12):1588-94
pubmed: 25442459
Circulation. 1989 Jun;79(6):1171-9
pubmed: 2785870
J Am Heart Assoc. 2018 Mar 31;7(7):
pubmed: 29605817
EuroIntervention. 2012 May 15;8(1):139-45
pubmed: 22580257
Clin Res Cardiol. 2018 Jun;107(6):449-459
pubmed: 29356881
Indian Heart J. 2018 Sep - Oct;70(5):745-749
pubmed: 30392516
Clin Res Cardiol. 2011 May;100(5):457-67
pubmed: 21165625
Circulation. 1982 Jul;66(1):14-22
pubmed: 6979435
Int J Angiol. 2011 Mar;20(1):33-8
pubmed: 22532768
Catheter Cardiovasc Interv. 2013 Jul 1;82(1):76-82
pubmed: 22888007
Am J Cardiol. 2017 Nov 15;120(10):1780-1786
pubmed: 28867125
JACC Cardiovasc Interv. 2015 Feb;8(2):245-253
pubmed: 25700746
J Card Surg. 2012 Mar;27(2):152-7
pubmed: 22364383
Circulation. 2016 May 3;133(18):1807-16
pubmed: 27143547
Clin Res Cardiol. 2016 Nov;105(11):921-929
pubmed: 27250096